We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Celgene, Biogen, Novartis, Allergan and Bausch Health added most to net prices, while lower net prices at Gilead Sciences, Johnson & Johnson, Novo Nordisk, GlaxoSmithKline and Sanofi dragged down the overall total.